<?xml version="1.0" encoding="utf-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.0.2//EN//XML" "art502.dtd" [<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2a SYSTEM "gr2a" NDATA IMAGE><!ENTITY gr2bc SYSTEM "gr2bc" NDATA IMAGE><!ENTITY gr3 SYSTEM "gr3" NDATA IMAGE><!ENTITY gr4 SYSTEM "gr4" NDATA IMAGE>]><article docsubtype="sco" xml:lang="en"><ce:floats xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:figure id="fig1"><ce:label>Fig. 1</ce:label><ce:caption><ce:simple-para>The interaction between endogenous PMCA and calcineurin A in human breast adenocarcinoma MCF-7 cells is isoform specific. Co-precipitation of PMCA2 or PMCA4 (but not PMCA1) and calcineurin using an antibody against calcineurin A demonstrates the physical interaction between the two proteins in MCF-7 cells. (α-CnA) anti-calcineurin A monoclonal antibody, (5F10) anti-PMCA monoclonal antibody, (α-luc) anti-luciferase antibody. Western blots of immunoprecipitated proteins were probed with antibodies specific for PMCA1, PMCA2, or PMCA4 (Swant) to detect PMCA1 (WB: PMCA1), PMCA2 (WB: PMCA2) and PMCA4 (WB: PMCA4), respectively.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Fig. 2</ce:label><ce:caption><ce:simple-para>The region 462–684 of human PMCA2b interacts with calcineurin A. (A) Schematic representation of FLAG-tagged proteins containing; the C-terminal (amino acids 1143–1243) intracellular region of human PMCA2b, the region 462–684 of its catalytic domain or the equivalent region (428–651) in the PMCA4b catalytic domain, and the small interaction domain 539–609 of hPMCA2b or the equivalent region (511–585) in hPMCA1b. (B) Immunoprecipitation analysis of the interaction between calcineurin A and the FLAG-tagged proteins described above. The region 462–684, located within the catalytic big intracellular loop of PMCA2b, specifically interacts with calcineurin A. A small fragment encompassing amino acids 539–609 of hPMCA2b still interacts with calcineurin, however, the equivalent sequence of hPMCA1b (511–585) failed to co-precipitate with calcineurin.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Fig. 3</ce:label><ce:caption><ce:simple-para>PMCA2b significantly inhibits NFAT transcriptional activity. PMCA2b inhibits the activation of an NFAT-dependent luciferase reporter vector in response to PMA plus Calcium ionophore (Io) A23187. 10<ce:hsp sp="0.25"/>μg of pcDNA3-hPMCA2b, pcDNA3-hPMCA1b or control vector pcDNA3, and 5<ce:hsp sp="0.25"/>μg of the NFAT-dependent luciferase reporter vector pNFAT-TA-Luc were co-transfected in HEK293 cells. Cells were stimulated with PMA (20<ce:hsp sp="0.25"/>ng/ml) plus Io (1<ce:hsp sp="0.25"/>μM) for 16<ce:hsp sp="0.25"/>h. Induction after PMA/Io stimulation of reporter vector luciferase activity in the presence of co-transfected control plasmid pcDNA3 was taken as reference (100%). Co-expression of human PMCA2b resulted in a significant reduction (32% inhibition) of luciferase induction. However, co-expression of human PMCA1b did not result in inhibition of the luciferase reporter vector. ∗, statistically significant (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>≤<ce:hsp sp="0.25"/>0.05, according to Student’s <ce:italic>t</ce:italic>-test). Means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>S.E. of three independent experiments are shown.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure></ce:floats><head><ce:title xmlns:ce="http://www.elsevier.com/xml/common/dtd">The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells</ce:title><ce:presented xmlns:ce="http://www.elsevier.com/xml/common/dtd">Edited by Michael R. Sussman</ce:presented><ce:author-group xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:author><ce:given-name>Marylouisa</ce:given-name><ce:surname>Holton</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Di</ce:given-name><ce:surname>Yang</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Weiguang</ce:given-name><ce:surname>Wang</ce:surname><ce:cross-ref refid="aff2"><ce:sup>b</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Tamer M.A.</ce:given-name><ce:surname>Mohamed</ce:surname><ce:cross-ref refid="aff3"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Ludwig</ce:given-name><ce:surname>Neyses</ce:surname><ce:cross-ref refid="aff3"><ce:sup>c</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Angel L.</ce:given-name><ce:surname>Armesilla</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1"><ce:sup>⁎</ce:sup></ce:cross-ref><ce:e-address type="email">A.Armesilla@wlv.ac.uk</ce:e-address></ce:author><ce:affiliation id="aff1"><ce:label>a</ce:label><ce:textfn>Molecular Pharmacology Group, Research Institute in Healthcare Sciences, School of Applied Sciences, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1SB, UK</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>b</ce:label><ce:textfn>Oncology Group, Research Institute in Healthcare Sciences, School of Applied Sciences, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1SB, UK</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>c</ce:label><ce:textfn>Division of Cardiology, Stopford Building, The University of Manchester, Oxford Road, Manchester M13 9PT, UK</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>⁎</ce:label><ce:text>Corresponding author. Fax: +44 01902 323465.</ce:text></ce:correspondence></ce:author-group><ce:abstract class="author" xml:lang="en" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Plasma membrane calcium/calmodulin-dependent ATPases (PMCAs) are high affinity calcium pumps that extrude calcium from the cell. Emerging evidence suggests a novel role for PMCAs as regulators of calcium/calmodulin-dependent signal transduction pathways via interaction with specific partner proteins. In this work, we demonstrate that endogenous human PMCA2 and -4 both interact with the signal transduction phosphatase, calcineurin, whereas, no interaction was detected with PMCA1. The strongest interaction was observed between PMCA2 and calcineurin. The domain of PMCA2 involved in the interaction is equivalent to that reported for PMCA4b. PMCA2–calcineurin interaction results in inhibition of the calcineurin/nuclear factor of activated T-cells signalling pathway.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords class="abr" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abbreviations</ce:section-title><ce:keyword><ce:text>PMCA</ce:text><ce:keyword><ce:text>plasma membrane calcium ATPase</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>NFAT</ce:text><ce:keyword><ce:text>nuclear factor of activated T-cells</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>HEK293</ce:text><ce:keyword><ce:text>human embryonic kidney cell</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>RIPA</ce:text><ce:keyword><ce:text>radioimmunoprecipitation assay</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>TBS-T</ce:text><ce:keyword><ce:text>Tris-buffered saline plus Tween 20</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>PMA</ce:text><ce:keyword><ce:text>phorbol-12 myristate 13-acetate</ce:text></ce:keyword></ce:keyword></ce:keywords><ce:keywords class="keyword" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>PMCA</ce:text></ce:keyword><ce:keyword><ce:text>Calcineurin</ce:text></ce:keyword><ce:keyword><ce:text>Interaction</ce:text></ce:keyword><ce:keyword><ce:text>MCF-7</ce:text></ce:keyword><ce:keyword><ce:text>Signalling</ce:text></ce:keyword><ce:keyword><ce:text>NFAT</ce:text></ce:keyword></ce:keywords></head><body><ce:sections xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section><ce:label>1</ce:label><ce:section-title>Introduction</ce:section-title><ce:para>Plasma membrane calcium P-type ATPases (PMCAs) are high affinity calcium pumps that contribute to the maintenance of intracellular calcium homeostasis by exporting calcium from the cytosol to the extracellular environment <ce:cross-ref refid="bib1">[1]</ce:cross-ref>.</ce:para><ce:para>There are four different isoforms of PMCA, numbered 1–4, encoded by four independent genes. PMCA1 and PMCA4 are expressed ubiquitously, whereas, PMCA2 and PMCA3 show a more restricted cell- and tissue-specific pattern of expression <ce:cross-ref refid="bib2">[2]</ce:cross-ref>.</ce:para><ce:para>Structurally, PMCAs consist of 10 transmembrane domains, two big intracellular loops, and N- and C-terminal cytoplasmic tails <ce:cross-ref refid="bib2">[2]</ce:cross-ref>.</ce:para><ce:para>The intracellular regions of PMCAs have been reported to mediate functional interactions with calcium/calmodulin-dependent enzymes, including nitric-oxide synthase I (nNOS) <ce:cross-ref refid="bib3">[3]</ce:cross-ref>, calcium/calmodulin-dependent serine protein kinase (CASK) <ce:cross-ref refid="bib4">[4]</ce:cross-ref> and, calcineurin <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. These interactions suggest that PMCA might act as a regulator of signal transduction pathways by tethering signalling proteins to cellular microenvironments where the concentrations of calcium and calmodulin are maintained at low levels. In this sense, the interaction between PMCA4 and calcineurin results in inhibition of the calcineurin/nuclear factor of activated T-cells (NFAT) signal transduction pathway <ce:cross-ref refid="bib5">[5]</ce:cross-ref>.</ce:para><ce:para>The calcineurin/NFAT pathway plays a critical role in the progression of several human pathologies <ce:cross-ref refid="bib6">[6]</ce:cross-ref>. At present, the only clinically available inhibitors for the calcineurin/NFAT pathway are the immunosuppressant drugs cyclosporine A and FK506, which are unfortunately associated with severe side effects <ce:cross-ref refid="bib7">[7]</ce:cross-ref>. The recent identification of ectopically expressed PMCA4 as an inhibitor of the calcineurin/NFAT pathway <ce:cross-ref refid="bib5">[5]</ce:cross-ref> has prompted us to further investigate the interaction between endogenous PMCA and calcineurin, and to extend our previous observations to the analyses of other PMCA isoforms in an attempt to characterise new cellular inhibitors of this pathway.</ce:para><ce:para>Here we demonstrate that the interaction between endogenous PMCA and calcineurin is isoform specific in MCF-7 human breast cancer cells. Endogenous PMCA2 and -4 both interact with calcineurin, whereas, no interaction has been detected for PMCA1. The strongest interaction was detected between PMCA2 and calcineurin A. PMCA2 interacts with calcineurin through a domain equivalent to that reported for PMCA4b <ce:cross-ref refid="bib5">[5]</ce:cross-ref> and also inhibits the calcineurin/NFAT signalling pathway.</ce:para></ce:section><ce:section role="materials-methods"><ce:label>2</ce:label><ce:section-title>Materials and methods</ce:section-title><ce:section><ce:label>2.1</ce:label><ce:section-title>Cell culture</ce:section-title><ce:para>Human embryonic kidney cell (HEK293) and MCF-7 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma–Aldrich) supplemented with 10% Fetal Calf Serum, 1% penicillin/streptomycin and 1% <ce:small-caps>l</ce:small-caps>-Glutamine.</ce:para></ce:section><ce:section><ce:label>2.2</ce:label><ce:section-title>Plasmids</ce:section-title><ce:para>pFlag-PMCA4b-(428–651) has been described previously <ce:cross-ref refid="bib5">[5]</ce:cross-ref>.</ce:para><ce:para>pcDNA3-hPMCA2b contains the human PMCA2b cDNA and was a gift from Prof. Carafoli (University of Padova, Italy).</ce:para><ce:para>pcDNA3-hPMCA1b contains the human PMCA1b cDNA cloned into the XhoI and KpnI cloning sites of pcDNA3.1(-) (Invitrogen).</ce:para><ce:para>A fragment of hPMCA2b encoding amino acids 462–684 was generated by 35 cycles of PCR (the conditions were denaturation at 94<ce:hsp sp="0.25"/>°C for 30<ce:hsp sp="0.25"/>s, annealing at 60<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min and extension at 72<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min) using oligonucleotides EcoPMCA2sense4 (5′-TCTTCCggAATTCTCCCgTCACCATCTCgTTgg-3′) and BamPMCA2anti684 (5′-CTTggCggATCCTCACTCCgggCTgCTggggAAgTC-3′) and plasmid pcDNA3-hPMCA2b as a template.</ce:para><ce:para>A fragment of hPMCA2b cDNA encoding amino acids 1143–1243 was amplified by 35 cycles of PCR (the conditions were denaturation at 94<ce:hsp sp="0.25"/>°C for 30<ce:hsp sp="0.25"/>s, annealing at 56<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min and extension at 72<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min) using oligonucleotides HindPMCA2sense1143 (5′-TCTTCCCAAgCTTgTCgTgAAggCgTTCCgTAg-3′) and BamPMCA2anti1243 (5′-CTTCgCggATCCTCAAAgCgACgTCTCCAggCTgT-3′) and plasmid pcDNA3-hPMCA2b as a template.</ce:para><ce:para>A fragment of hPMCA2b cDNA encoding amino acids 535–609 was amplified by 35 cycles of PCR (the conditions were denaturation at 94<ce:hsp sp="0.25"/>°C for 30<ce:hsp sp="0.25"/>s, annealing at 60<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min and extension at 72<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min 30<ce:hsp sp="0.25"/>s) using oligonucleotides HindPMCA2sense535 (5′-TCTTCCCAAgCTTATggAgCTgCTgATCAATgCC-3′) and BamPMCA2anti609 (5′-CTTCgCggATCCTCACATggACTTgCgCACggAgTTg-3′) and plasmid pcDNA3-hPMCA2b as a template.</ce:para><ce:para>Amplified fragments 462–684, 535–609 and 1143–1243 were digested with EcoRI and BamHI, and HindIII and BamHI, respectively, and cloned into the corresponding sites of p3xFlag-CMV7.1 (Sigma–Aldrich). The resulting plasmids, pFlag-PMCA2b (462–684), pFlag-PMCA2b (535–609) and pFlag-PMCA2b (1143–1243), encode flag-tagged PMCA2b truncated proteins containing amino acids 462–684, 535–609 and 1143–1243, respectively, (numbering according to Genbank<ce:sup>NM</ce:sup> Accession No. <ce:inter-ref xlink:href="genbank:NM_001683" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">NM_001683</ce:inter-ref>).</ce:para><ce:para>A fragment of hPMCA1b cDNA encoding amino acids 511–585 was amplified by 35 cycles of PCR (the conditions were denaturation at 94<ce:hsp sp="0.25"/>°C for 30<ce:hsp sp="0.25"/>s, annealing at 56<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min and extension at 72<ce:hsp sp="0.25"/>°C for 1<ce:hsp sp="0.25"/>min 30<ce:hsp sp="0.25"/>s) using oligonucleotides EcoPMCA1sense511 (5′-TCTTCCggAATTCTTTgTCCTATCTTgTAACAggAA-3′) and BamPMCA1anti585 (5′-CTTCgCggATCCTCACATggACTTCCTAACAgAATTg-3′) and plasmid pcDNA3-hPMCA1b as a template.</ce:para><ce:para>Amplified fragment 511–585 was digested with EcoRI and BamHI, and cloned into the corresponding sites of p3xFlag-CMV7.1 (Sigma–Aldrich). The resulting plasmid, pFlag-PMCA1b (511–585), encodes a flag-tagged PMCA1b truncated protein containing amino acids 511–585 (numbering according to Genbank<ce:sup>NM</ce:sup> Accession No. <ce:inter-ref xlink:href="genbank:J04027" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">J04027</ce:inter-ref>).</ce:para><ce:para>The fidelity of all amplified products was confirmed by sequencing.</ce:para></ce:section><ce:section><ce:label>2.3</ce:label><ce:section-title>Transient transfections</ce:section-title><ce:para>For immunoprecipitation experiments, HEK 293 cells were plated in 100<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>20-mm tissue culture dishes (4.5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup>6</ce:sup><ce:hsp sp="0.25"/>cells/plate) the day before transfection. Cells were transfected with 10<ce:hsp sp="0.25"/>μg of the indicated expression plasmids by using LipofectAMINE 2000 reagent (Invitrogen) as previously described <ce:cross-ref refid="bib8">[8]</ce:cross-ref>.</ce:para><ce:para>For luciferase assays, HEK293 cells were plated in 6-well tissue culture plates (0.5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup>6</ce:sup> cells/well) the day before transfection. Cells were transfected with 10<ce:hsp sp="0.25"/>μg of an expression vector encoding human PMCA2b (pcDNA3-hPMCA2b) or the corresponding empty vector (pcDNA3) and 5<ce:hsp sp="0.25"/>μg of the luciferase reporter pNFAT-TA-Luc (Clontech) by using LipofectAMINE2000 reagent (Invitrogen) as previously described <ce:cross-ref refid="bib8">[8]</ce:cross-ref>. Cells were stimulated with phorbol-12 myristate 13-acetate (PMA) (20<ce:hsp sp="0.25"/>ng/ml) and the calcium ionophore A23187 (1<ce:hsp sp="0.25"/>μM) for 16<ce:hsp sp="0.25"/>h and luciferase activity determined as described <ce:cross-ref refid="bib8">[8]</ce:cross-ref>. Transfection efficiency was normalised by co-transfection of plasmid pEF-LacZ and determination of β-galactosidase activity <ce:cross-ref refid="bib9">[9]</ce:cross-ref>.</ce:para></ce:section><ce:section><ce:label>2.4</ce:label><ce:section-title>Immunoprecipitation</ce:section-title><ce:para>MCF-7 or transfected HEK293 cells were lysed as described <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. One milliliter extracts were incubated overnight with the corresponding immunoprecipitating antibodies and 40<ce:hsp sp="0.25"/>μl of protein A-agarose beads (Roche), at 4<ce:hsp sp="0.25"/>°C with shaking. Beads were recovered by centrifugation at 3000<ce:hsp sp="0.25"/>rpm and washed three times with 500<ce:hsp sp="0.25"/>μl of radioimmunoprecipitation assay (RIPA) buffer. Washed beads were resuspended in 60<ce:hsp sp="0.25"/>μl of 2<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>SDS–PAGE loading buffer (Invitrogen) and analyzed by Western blot.</ce:para></ce:section><ce:section><ce:label>2.5</ce:label><ce:section-title>Western blot</ce:section-title><ce:para>Samples were boiled and resolved as previously described <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. Western blot membranes were incubated at room temperature with a 0.1% (v/v) solution of anti-Flag M2 peroxidase-conjugated monoclonal antibody (Sigma–Aldrich) in Tris-buffered saline plus Tween 20 (TBS-T) (for Flag-epitope detection) or with a 0.25% (v/v) solution of isoform specific rabbit polyclonal anti-PMCA antibody (Swant) for detection of the corresponding isoform of PMCA for 3<ce:hsp sp="0.25"/>h. Bound antibodies were detected by ECL as described <ce:cross-ref refid="bib5">[5]</ce:cross-ref>.</ce:para></ce:section></ce:section><ce:section><ce:label>3</ce:label><ce:section-title>Results</ce:section-title><ce:section><ce:label>3.1</ce:label><ce:section-title>Co-precipitation of endogenous human PMCA and calcineurin A in human breast adenocarcinoma cells</ce:section-title><ce:para>To investigate the interaction between endogenous PMCA isoforms 1, 2 or 4 and calcineurin A in human breast adenocarcinoma cells, protein extracts were immunoprecipitated with a monoclonal anti-calcineurin A antibody (Sigma) and precipitated proteins were probed by western blot using isoform specific anti-PMCA antibodies (Swant).</ce:para><ce:para>A very faint but reproducible band corresponding to PMCA4 was detected in samples probed with a rabbit anti-PMCA4 antibody (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref><ce:float-anchor refid="fig1"/>, upper panel) suggesting a weak interaction between endogenous calcineurin A and human PMCA4 in MCF-7 cells. Control immunoprecipitations carried out with the 5F10 anti-PMCA monoclonal antibody revealed the presence of high levels of the PMCA4 isoform in MCF-7 cells (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>, upper panel) indicating that the weak band detected was not attributable to low expression levels of PMCA4 or low affinity of the antibody.</ce:para><ce:para>Western blot with an anti-PMCA2 antibody showed high levels of co-precipitated PMCA2 (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>, middle panel) suggesting a strong interaction between endogenous calcineurin A and human PMCA2.</ce:para><ce:para>Immunoprecipitation of calcineurin A failed to co-precipitate PMCA1 in MCF-7 cells as evidenced by the absence of PMCA1 detection when the precipitated proteins were probed with an antibody recognising specifically PMCA1 (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>, lower panel). This finding suggests a lack of interaction between endogenous calcineurin A and PMCA1 in human MCF-7 cells. Immunoprecipitation performed with the 5F10 anti-PMCA antibody precipitated high levels of PMCA1 protein (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>, lower panel) ruling out low expression levels of PMCA1 as the cause for lack of interaction with calcineurin A.</ce:para><ce:para>In all cases, control immunoprecipitations carried out with an irrelevant antibody (anti-luciferase) precipitated no protein at all, confirming the selectivity of the interactions (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>).</ce:para><ce:para>In summary, these results indicate that the interaction between endogenous calcineurin A and PMCAs is isoform specific and suggest that calcineurin A interacts very strongly with endogenous PMCA2 but very weakly with PMCA4 in human breast adenocarcinoma cells.</ce:para></ce:section><ce:section><ce:label>3.2</ce:label><ce:section-title>The region 462–684 of PMCA2b is essential for interaction with calcineurin A</ce:section-title><ce:para>We have previously reported that the region encompassing amino acids 428–651 of human PMCA4b is involved in the interaction with calcineurin A <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. Comparison of the sequence for the equivalent region in PMCA2b revealed a high degree (76%) of amino acid homology suggesting that this region might be involved in the interaction with calcineurin A. To test this hypothesis, we generated FLAG-tagged fusion proteins containing the region spanning amino acids 462–684, or 1143–1243 of PMCA2b (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref><ce:float-anchor refid="fig2"/>A).</ce:para><ce:para>HEK293 cells were transfected with plasmids pF-PMCA2b-(462–684) or -(1143–1243). Commercially available calcineurin A (Sigma) was added to the protein lysates to a final concentration 40<ce:hsp sp="0.25"/>nM. Protein lysates were then immunoprecipitated by overnight incubation with monoclonal anti-calcineurin A antibody, and, subsequently, probed by western blot. FLAG-PMCA2b-(462–684) co-precipitated with calcineurin A (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, left upper panel). No precipitation was observed for FLAG-PMCA2b-(1143–1243) demonstrating the selectivity of the interaction (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, left upper panel). Cells transfected with pF-PMCA4b-(428–651) were used as a positive control (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, left upper panel) <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. These results demonstrate that the region 462–684 of the catalytic large intracellular loop of PMCA2b is implicated in the interaction with calcineurin A.</ce:para><ce:para>Our previous observations for human PMCA4b suggested that the fragment 501–575 of PMCA4b is essential for the interaction of this protein with calcineurin <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. To test the ability of the equivalent region in hPMCA2b (fragment 535–609) to interact with calcineurin we generated a Flag-tagged fusion protein containing this region (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>A). Flag-hPMCA2b(535–609) co-precipitated with calcineurin (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, right upper panel) although to a lesser degree than that observed with the full fragment (462–684) suggesting that adjacent sequences might contribute to the interaction. This result indicates that the region 535–609 of PMCA2b interacts with calcineurin.</ce:para><ce:para>A Flag-tagged fusion protein containing the equivalent sequence for hPMCA1b, Flag-hPMCA1b(511–585) (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>A), failed to co-precipitate with calcineurin (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, right upper panel), confirming the lack of interaction observed between endogenous PMCA1 and calcineurin.</ce:para><ce:para>Western blot analysis of the protein lysates prior to immunoprecipitation showed expression of the corresponding Flag-tagged fusion proteins, disproving that lack of expression may have led to a lack of interaction (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B, lower panels).</ce:para></ce:section><ce:section><ce:label>3.3</ce:label><ce:section-title>PMCA2b significantly inhibits NFAT transcriptional activity</ce:section-title><ce:para>Previous investigations have reported that PMCA4b negatively regulates the activity of endogenous calcineurin A in mammalian cells <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. We speculated that PMCA2 could also function as an inhibitor of the calcineurin/NFAT pathway.</ce:para><ce:para>HEK293 cells were co-transfected with pcDNA3 (empty plasmid) and the NFAT-dependent luciferase reporter vector pNFAT-TA-Luc (Clontech) and then stimulated with PMA and the calcium ionophore A23987 (Io) to induce calcineurin A activation and consequent NFAT transcriptional activity. Co-transfection of pNFAT-TA-Luc with pcDNA3-hPMCA2b, an expression plasmid encoding hPMCA2b, significantly reduced (32% inhibition, <ce:italic>P</ce:italic><ce:hsp sp="0.25"/>≤<ce:hsp sp="0.25"/>0.05) PMA plus Io-dependent activation of the luciferase reported vector (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref><ce:float-anchor refid="fig3"/>). These results suggest that PMCA2b negatively regulates the activity of endogenous calcineurin A in mammalian cells.</ce:para><ce:para>In agreement with the lack of interaction observed between endogenous hPMCA1b and calcineurin, co-transfection of pNFAT-TA-Luc with pcDNA3-hPMCA1b, an expression plasmid encoding human PMCA1b, did not result in inhibition of the luciferase reporter vector (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>).</ce:para></ce:section></ce:section><ce:section><ce:label>4</ce:label><ce:section-title>Discussion</ce:section-title><ce:para>In this investigation we have shown that the interaction between endogenous PMCA and calcineurin is isoform specific in MCF-7 breast adenocarcinoma cells. A strong interaction was detected between PMCA2 and calcineurin A. Expression of PMCA2 leads to inhibition of the calcineurin/NFAT pathway.</ce:para><ce:para>Emerging evidence indicates a major role for PMCA2 in mammary gland physiology; PMCA2b is highly expressed in lactating mammary tissues <ce:cross-ref refid="bib10">[10]</ce:cross-ref>, mice homozygous for a null-mutation of the <ce:italic>pmca2</ce:italic> gene produced milk with 60% less calcium than wild type animals <ce:cross-ref refid="bib11">[11]</ce:cross-ref> and expression of PMCA2 is up-regulated in breast cancer cell lines <ce:cross-ref refid="bib12">[12]</ce:cross-ref>. These findings suggest that deregulation of PMCA might contribute to breast tumorigenesis.</ce:para><ce:para>In this work, we demonstrate that PMCA2 inhibits the calcineurin/NFAT pathway. Increased PMCA2 expression in breast cancer is, therefore, expected to inhibit the calcineurin/NFAT pathway. High calcineurin activity leads to apoptosis <ce:cross-ref refid="bib13">[13]</ce:cross-ref> thereby, PMCA2-mediated down-regulation of calcineurin activity might result in inhibition of apoptosis and promotion of tumorigenesis in cancer cells. In agreement with this hypothesis, Padma et al. <ce:cross-ref refid="bib14">[14]</ce:cross-ref> have shown that calcineurin activity is down-regulated in cervical carcinoma. It would be interesting to analyse the level of PMCA2 expression in these cells and determine if it regulates calcineurin activity and, therefore, apoptosis in cervical carcinomas.</ce:para><ce:para>PMCA2-mediated inhibition of calcineurin and, therefore, calcineurin-mediated apoptosis, may also be involved in the hearing deficits observed in PMCA2-deficient mice <ce:cross-ref refid="bib15">[15]</ce:cross-ref>. High levels of PMCA2 have been found in the outer hair cells of the cochlea <ce:cross-ref refid="bib16">[16]</ce:cross-ref>. Impairment by mutation of PMCA2 function in deafwaddler mice (dfw/dfw) results in apoptotic hair cell death <ce:cross-ref refid="bib17">[17]</ce:cross-ref>. Lack of functional PMCA2 in the deafwaddler mouse might lead to an increase in calcineurin activity that would result in calcineurin-mediated apoptosis of outer hair cells. In accordance with this hypothesis, heightened activity of calcineurin has been shown to increase apoptosis of outer hair cells and promote cochlear acoustic injury <ce:cross-ref refid="bib18">[18]</ce:cross-ref>. Moreover, Minami et al. <ce:cross-ref refid="bib19">[19]</ce:cross-ref> have reported that the calcineurin inhibitors, FK506 and cyclosporine A, reduce noise-induced hair cell death. Therefore, it is highly probable that the interaction between PMCA and calcineurin is a major regulator of apoptosis in hair cells.</ce:para><ce:para>In conclusion, our results demonstrate that the interaction between endogenous PMCA and calcineurin is isoform-specific in MCF-7 adenocarcinoma cells and suggest that this interaction might play an important role in the regulation of breast tumorigenesis and hearing loss.</ce:para></ce:section></ce:sections><ce:acknowledgment xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Acknowledgements</ce:section-title><ce:para>We thank Prof. Ernesto Carafoli (University of Padova, Italy) for providing the pcDNA3-hPMCA2b plasmid. M.H. is the recipient of a PhD studentship funded by the Research Institute in Healthcare Science, University of Wolverhampton.</ce:para></ce:acknowledgment></body><tail><ce:bibliography xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>[1]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Carafoli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Biogenesis: plasma membrane calcium ATPase: 15 years of work on the purified enzyme</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FASEB J.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>993</sb:first-page><sb:last-page>1002</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>[2]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>E.E.</ce:given-name><ce:surname>Strehler</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Zacharias</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Physiol. Rev.</sb:maintitle></sb:title><sb:volume-nr>81</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>21</sb:first-page><sb:last-page>50</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>[3]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schuh</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Uldrijan</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Telkamp</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Rothlein</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Neyses</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The plasma membrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>155</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>201</sb:first-page><sb:last-page>205</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>[4]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schuh</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Uldrijan</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Gambaryan</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Roethlein</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Neyses</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Interaction of the plasma membrane Ca<ce:sup>2+</ce:sup> pump 4b/CI with the Ca<ce:sup>2+</ce:sup>/calmodulin-dependent membrane associated kinase CASK</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>278</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>9778</sb:first-page><sb:last-page>9783</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>[5]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Buch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pickard</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rodriguez</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Gillies</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Maas</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Emerson</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Cartwright</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Wiliams</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Oceandy</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Redondo</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Neyses</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Armesilla</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>280</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>29479</sb:first-page><sb:last-page>29487</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>[6]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>G.R.</ce:given-name><ce:surname>Crabtree</ce:surname></sb:author><sb:author><ce:given-name>E.N.</ce:given-name><ce:surname>Olson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NFAT signalling: choreographing the social lives of cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>109</sb:volume-nr></sb:series><sb:issue-nr>Suppl.</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>S67</sb:first-page><sb:last-page>S79</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>[7]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Martinez-Martinez</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Redondo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Inhibitors of the calcineurin/NFAT pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Med. Chem.</sb:maintitle></sb:title><sb:volume-nr>11</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>997</sb:first-page><sb:last-page>1007</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>[8]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Armesilla</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Buch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pickard</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Emerson</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Cartwright</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Oceandry</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Vos</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Gilles</ce:surname></sb:author><sb:author><ce:given-name>G.J.</ce:given-name><ce:surname>Clark</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Neyses</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Novel functional interaction between the plasma membrane calcium ATPase pump 4b and the proapoptopic tumor suppressor Ras-associated factor 1 (RASSF1)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>279</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>31318</sb:first-page><sb:last-page>31328</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>[9]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Sambrook</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Fritsch</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Maniatis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Molecular Cloning: A Laboratory Manual</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>1989</sb:date><sb:publisher><sb:name>Cold Spring Harbor Laboratory Press</sb:name><sb:location>Cold Spring Harbor, NY</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>[10]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Reinhardt</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Filoteo</ce:surname></sb:author><sb:author><ce:given-name>J.T.</ce:given-name><ce:surname>Penniston</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Horst</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ca(2+)-ATPase protein expression in mammary tissue</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Cell Physiol.</sb:maintitle></sb:title><sb:volume-nr>279</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>C1595</sb:first-page><sb:last-page>C1602</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>[11]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Reinhardt</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Lippolis</ce:surname></sb:author><sb:author><ce:given-name>G.E.</ce:given-name><ce:surname>Shull</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Horst</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Null mutation in the gene encoding plasma membrane Ca<ce:sup>2+</ce:sup>-ATPase isoform 2 impairs calcium transport into milk</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>279</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>42369</sb:first-page><sb:last-page>42373</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>[12]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>W.J.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Roberts-Thomson</ce:surname></sb:author><sb:author><ce:given-name>G.R.</ce:given-name><ce:surname>Monteith</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Plasma membrane calcium ATPase 2 and 4 in human breast cancer cell lines</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. Biophys. Res. Commun.</sb:maintitle></sb:title><sb:volume-nr>337</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>779</sb:first-page><sb:last-page>783</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>[13]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Asai</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Qiu</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Narita</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Chi</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Saito</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Shinoura</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Hamada</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Kuchino</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>kirino</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>High level calcineurin activity predisposes neuronal cells to apoptosis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>274</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>34450</sb:first-page><sb:last-page>34458</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>[14]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Padma</ce:surname></sb:author><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Sowjanya</ce:surname></sb:author><sb:author><ce:given-name>U.R.</ce:given-name><ce:surname>Poli</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Jain</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Rao</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Ramakrishna</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Downregulation of calcineurin activity in cervical carcinoma</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cancer Cell Int.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>7</sb:first-page><sb:last-page>14</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>[15]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Kozel</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Friedman</ce:surname></sb:author><sb:author><ce:given-name>L.C.</ce:given-name><ce:surname>Erway</ce:surname></sb:author><sb:author><ce:given-name>E.N.</ce:given-name><ce:surname>Yamoah</ce:surname></sb:author><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Riddle</ce:surname></sb:author><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Duffy</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Doetschman</ce:surname></sb:author><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Miller</ce:surname></sb:author><sb:author><ce:given-name>E.L.</ce:given-name><ce:surname>Cardell</ce:surname></sb:author><sb:author><ce:given-name>G.E.</ce:given-name><ce:surname>Shull</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Balance and hearing deficits in mice with a null mutation in the gene encoding plasma membrane Ca<ce:sup>2+</ce:sup>-ATPase isoform 2</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>273</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>18693</sb:first-page><sb:last-page>18696</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>[16]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Furuta</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Luo</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hepler</ce:surname></sb:author><sb:author><ce:given-name>A.F.</ce:given-name><ce:surname>Ryan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Evidence for differential regulation of calcium by outer versus inner hair cells: plasma membrane Ca-ATPase gene expression</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hear. Res.</sb:maintitle></sb:title><sb:volume-nr>123</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>10</sb:first-page><sb:last-page>26</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>[17]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Dodson</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Charalabapoulou</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>PMCA2 mutation causes structural changes in the auditory system in deafwaddler mice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurocytol.</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>281</sb:first-page><sb:last-page>292</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>[18]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Vicente-Torres</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Schacht</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A BAD link to mitochondrial cell death in the cochlea of mice with noise-induced hearing loss</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci. Res.</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1564</sb:first-page><sb:last-page>1572</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>[19]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.B.</ce:given-name><ce:surname>Minami</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Yamashita</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Schacht</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Miller</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Calcineurin activation contributes to noise-induced hearing loss</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci. Res.</sb:maintitle></sb:title><sb:volume-nr>78</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>383</sb:first-page><sb:last-page>392</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>
